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Orai/CRACM1 and KCa3.1 ion channels interact
in the human lung mast cell plasma membrane
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Abstract
Background: Orai/CRACM1 ion channels provide the major Ca2+ influx pathway for FcεRI-dependent human lung
mast cell (HLMC) mediator release. The Ca2+-activated K+ channel KCa3.1 modulates Ca
2+ influx and the secretory
response through hyperpolarisation of the plasma membrane. We hypothesised that there is a close functional and
spatiotemporal interaction between these Ca2+- and K+-selective channels.
Results: Activation of FcεRI-dependent HLMC KCa3.1 currents was dependent on the presence of extracellular Ca2+,
and attenuated in the presence of the selective Orai blocker GSK-7975A. Currents elicited by the KCa3.1 opener
1-EBIO were also attenuated by GSK-7975A. The Orai1 E106Q dominant-negative mutant ablated 1-EBIO and
FcεRI-dependent KCa3.1 currents in HLMCs. Orai1 but not Orai2 was shown to co-immunoprecipitate with KCa3.1
when overexpressed in HEK293 cells, and Orai1 and KCa3.1 were seen to co-localise in the HEK293 plasma
membrane using confocal microscopy.
Conclusion: KCa3.1 activation in HLMCs is highly dependent on Ca
2+ influx through Orai1 channels, mediated via a
close spatiotemporal interaction between the two channels.
Keywords: Orai, KCa3.1, Mast cell
Background
The aberrant activation of mast cells via the high affinity
IgE receptor FcεRI results in the release of preformed
granule-derived mediators such as histamine and tryp-
tase, the synthesis and release of lipid mediators such as
leukotriene (LT)C4 and prostaglandin (PG)D2, and the
generation of numerous cytokines, including IL-4, IL-5
and IL-13 [1]. This process contributes to the patho-
physiology of allergic diseases such as asthma, rhinitis,
urticaria and anaphylaxis [1].
The influx of extracellular Ca2+ is an essential require-
ment for the FcεRI-dependent release of mast cell medi-
ators [2]. Members of the recently discovered Orai (also
known as CRACM) ion channel family provide the
major pathway for this influx in both rodent and human
lung mast cells (HLMCs) [3–5]. These channels carry
Ca2+ selective currents (ICRAC) that are activated when
endoplasmic reticulum (ER) Ca2+ stores are emptied.
The family contains three members Orai1, Orai2 and
Orai3 [6, 7]. They show a high degree of sequence hom-
ology but have distinct functional properties [6, 7]. The
channel pore is contained within the Orai channel sub-
unit [8–11]. An ER membrane protein, STIM1, acts as
the sensor of the ER Ca2+ concentration and transmits
this information to the channel pore [12]. Human and
rodent mast cells express all three Orai subunits at the
mRNA level, although Orai1 is the dominant channel
which is activated following cross-linking of FcεRI [3–5].
In HLMCs pharmacological block of Orai channels re-
duces Ca2+ influx, degranulation, LTC4 release and cyto-
kine secretion [3]. Similarly, Ca2+ influx, degranulation,
LTC4 release and TNFα production are all greatly re-
duced in foetal liver-derived mast cells from an Orai1
knockout mouse [4].
Both human and rodent mast cells also express functional
intermediate conductance Ca2+ activated K+ channels
(KCa3.1) [13–15]. In human mast cells KCa3.1 constitutes
the major K+ selective conductance [13, 14]. KCa3.1 chan-
nels are activated in mast cells by a rise in the cytosolic free
Ca2+ concentration following FcεRI-dependent activation.
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Calmodulin, which is tightly bound near the C-terminus of
the KCa3.1subunit, acts as the Ca
2+ sensor. The key conse-
quence of KCa3.1 opening during cell activation is the
hyperpolarisation of the cell membrane. This maintains the
electrical driving force for Ca2+ influx through store oper-
ated channels such as Orai, and enhances Ca2+ influx
through Orai channels because they are strongly inwardly
rectifying and therefore conduct larger currents at negative
membrane potentials [16]. Thus, activation of KCa3.1 chan-
nels using the KCa3.1 channel opener 1-ethyl-2-benzimida-
zolinone (1-EBIO) enhanced IgE-dependent Ca2+ influx
and degranulation in HLMCs [14]. In contrast IgE-
dependent Ca2+ influx and degranulation was significantly
reduced in bone-marrow derived mast cells isolated from a
KCa3.1 knockout mouse [15]. KCa3.1 has also been shown
to be important for HLMC migration [17].
KCa3.1 channel activity disappears when extracellular
Ca2+ is removed from cultured human mast cells that
have been activated through FcεRI [13], and channel activ-
ity is not induced by several stimuli that release Ca2+ from
intracellular stores but which do not stimulate Ca2+ influx
[17]. In addition, KCa3.1 currents were not elicited in
HLMCs activated by the Ca2+ ionophore A23187 [13].
This suggests that the activation of KCa3.1 channels by
Ca2+ under physiological conditions relies on a tight spa-
tiotemporal Ca2+ signal provide by Ca2+ influx channels.
We therefore hypothesised that there is a close functional
relationship between KCa3.1 and Orai channels in
HLMCs, and that the two channels may interact physically
to maintain tight spatiotemporal control of their activity.
To test this hypothesis we have examined the effects of
Orai channel inhibition in HLMCs on KCa3.1 channel ac-
tivity and used co-immunoprecipitation and confocal mi-
croscopy to examine the physical interaction between
KCa3.1 and Orai channels in co-transfected HEK293 cells.
Results
KCa3.1 requires extracellular Ca
2+ for activation by FcεRI
cross-linking in HLMCs
HLMC activation via FcεRI stimulates the release of Ca2+
from intracellular stores followed by the influx of extracel-
lular Ca2+ through Orai channels. Influx of extracellular
Ca2+ is essential for HLMC degranulation and lipid medi-
ator synthesis [2].
We showed previously that KCa3.1 currents elicited in
human mast cells by FcεRI-dependent activation dis-
appear on removal of extracellular Ca2+, demonstrating
the need for extracellular Ca2+ influx for the mainten-
ance of KCa3.1 activity [13]. Here, activation of HLMCs
by cross-linking FcεRI in the presence of extracellular
Ca2+ evoked typical KCa3.1 currents as previously de-
scribed in 81 % of cells studied, with a mean whole cell
current at +40 mV in responding cells increasing from
6.8 ± 0.8 pA (reversal potential −31.4 ± 3.2 mV) at
baseline to 75.6 ± 7.6 pA post anti-FcεRI (reversal poten-
tial −72.0 ± 9.3 mV) (n = 27 cells) (p < 0.0001 and p <
0.0001 for current and reversal potential respectively
compared to baseline) (Fig. 1a). In contrast, in the ab-
sence of extracellular Ca2+, no KCa3.1 currents develo-
ped:current at +40 mV pre and post anti-FcεRI 4.5 ± 1.2
pA and 5.5 ± 1.1 pA respectively (p = 0.42), reversal
potential pre and post anti-FcεRI −24.2 ± 1.8 mV and
−22.0 ± 2.0 mV respectively (p = 0.71)(n = 9 cells)(Fig. 1b).
Subsequent addition of extracellular Ca2+ (2 mM) to
these cells following FcεRI-dependent activation induced
only small KCa3.1 currents (11.0 ± 5.4 pA at +40 mV,
p = 0.017 compared to no Ca2+) and a significant shift in
reversal potential (−43.8 ± 7.4 mV, p = 0.015 compared
to no Ca2+)(Fig. 1b). The small KCa3.1 currents seen here
on subsequent addition Ca2+ here are in keeping with
the known desensitisation of signalling pathways that
occur when FcεRI is activated in the absence of extracel-
lular Ca2+ [18, 19].
Fig. 1 FcεRI-dependent HLMC KCa3.1 currents require the presence
of external Ca2+. a Current–voltage curves from HLMCs activated via
FcεRI in the presence external Ca2+ (2 mM). b Current–voltage
curves from HLMCs activated via FcεRI in the absence of external
Ca2+. Typical KCa3.1 currents appear in the presence of Ca
2+ (2 mM)
but not when it is absent. Small KCa3.1 currents appear in (b) when
Ca2+ is then introduced. Data presented as mean ± SEM
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In summary, Ca2+ influx from the extracellular fluid is a
critical requirement for the initial opening of KCa3.1 after
FcεRI-dependent activation in HLMCs, as well as its main-
tenance following activation as described previously [13].
Orai channel block attenuates KCa3.1 activation
To assess whether Ca2+ influx through Orai channels
contributes to KCa3.1 opening, we used the selective
Orai channel blocker, GSK-7975A (a kind gift GlaxoS-
mithKline) [3, 20]. KCa3.1 currents elicited in response
to FcεRI-dependent HLMC activation were significantly
attenuated with the subsequent addition of 1 μM GSK-
7975A, a concentration that suppresses Orai currents by
>90 % in our hands [3] (Fig. 2a). Thus baseline whole
cell currents of 6.8 ± 0.8 pA at +40 mV increased to
75.6 ± 7.6 pA post anti-FcεRI and were reduced to 40.9
± 4.7 pA following addition of GSK-7975A (p < 0.0001,
n = 27 cells). A small but significant positive shift in re-
versal potential was also evident with the addition of
GSK-7975A (post anti-FcεRI −72.0 ± 9.3 mV, post GSK-
7975A −61.3 ± 6.7 mV, p = 0.009) (Fig. 2a).
1-EBIO opens KCa3.1 by enhancing its sensitivity to
[Ca2+]i. Thus at 100 μM EBIO, maximal K
+ currents are
achieved in the presence of 100 nM free Ca2+ [21],
which is below the resting [Ca2+]i of most cell types in-
cluding HLMCs [14]. Interestingly, 1-EBIO-dependent
KCa3.1 currents were also attenuated although to a lesser
degree by GSK-7975A (Fig. 2b). Thus baseline whole cell
currents of 7.4 ± 0.8 pA at +40 mV increased to 76.8 ±
8.8 pA post 1-EBIO, and were reduced to 59.4 ± 7.2 pA
following addition of GSK-7975A (p < 0.0001, n = 29
cells). The reduction in KCa3.1 current induced by GSK-
7975A following FcεRI-dependent HLMC activation was
significantly greater than following 1-EBIO-dependent
KCa3.1 activation (p = 0.039).
To confirm that GSK-7975A does not directly block
KCa3.1 currents, GFP-KCa3.1 was overexpressed in
HLMCs. This generated large (nA) constitutively active
KCa3.1 currents that were not blocked by GSK-7975A
(1 μM)(Fig. 2c).
The Orai1 E106Q dominant-negative mutant ablates
KCa3.1 currents
To further investigate the role of Orai channels in the
regulation of KCa3.1 in HLMCs, the effect of a dominant-
negative mutant of Orai1 (E106Q) was assessed [5]. While
7/7 GFP-transduced control HLMCs expressed robust
KCa3.1 currents following exposure to 1-EBIO (net current
at +40 mV 40.9 ± 19.5 pA, n = 7 cells), no KCa3.1 currents
could be elicited in cells transduced with Orai1-E106Q
(net current at +40 mV −1.1 pA, n = 6 cells, p = 0.04 com-
pared to GFP) (Fig. 3a and b).
Similarly 8/8 GFP-transduced control HLMCs expressed
robust KCa3.1 currents following exposure to anti-FcεRI
Fig. 2 FcεRI- and 1-EBIO-dependent HLMC KCa3.1 currents are
attenuated by an Orai channel blocker. a KCa3.1 currents induced
following FcεRI-dependent activation are attenuated in HLMCs
following addition of the Orai channel blocker GSK-7975A (n = 27 cells).
b KCa3.1 currents induced following 1-EBIO-dependent activation are
attenuated following addition of the Orai channel blocker GSK-7975A
(n = 29 cells). Data presented as mean ± SEM. c Overexpressed KCa3.1
channels in HLMCs were constitutively active and were not blocked by
GSK-7975A (1 μM)(n = 4 cells, p = 0.43 at +40 mV)
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(net current at +40 mV 121.6 ± 34.2 pA, n = 8 cells), but no
FcεRI-dependent KCa3.1 currents could be elicited in cells
transduced with Orai1-E106Q (net current at +40 mV 4.1
± 3.2 pA, n = 9 cells, p = 0.0023 compared to GFP)(Fig. 3b).
Orai1 but not Orai2 co-immunoprecipitates with KCa3.1
The proposed functional interaction between Orai and
KCa3.1 channels in HLMCs led us to investigate whether
these channels interact physically. We therefore
expressed myc epitope-tagged Orai1 and Orai2 and
FLAG epitope-tagged KCa3.1 in HEK293 cells and tested
for potential interactions by co-immunoprecipitation.
Expression of epitope tagged channels was confirmed by
Western blotting using antibodies raised against the ap-
propriate epitope tag (Fig. 4a). Multiple bands were ob-
served on blotting for KCa3.1-FLAG protein using an
anti-FLAG antibody, with band sizes of 48 kDa (the pre-
dicted size of KCa3.1), and less. A similar band pattern
has recently been observed on Western blotting for
KCa3.1 in human fibrocytes, lung fibroblasts and airway
smooth muscle cells, and may reflect differential splicing
modification [22–24]. When an anti c-myc antibody was
used to immunoprecipitate Orai1-myc protein, KCa3.1-
FLAG was found to be co-immunoprecipitated (Fig. 4b).
Co-immunoprecipitation of KCa3.1-FLAG was observed
only from lysates of cells expressing both Orai1-myc and
KCa3.1-FLAG proteins. Similarly when an anti-FLAG
antibody was used to immunoprecipitate KCa3.1-FLAG
protein, Orai1-myc protein was co-immunoprecipitated
Fig. 3 FcεRI- and 1-EBIO-dependent HLMC KCa3.1 currents are
inhibited by expression of an Orai1-E106Q dominant-negative mutant.
Transduction of HLMCs with an Orai1-E106Q dominant-negative
mutant ablated (a) 1-EBIO- dependent and (b) FcεRI-dependent KCa3.1
currents. For clarity, data are presented as the subtracted net
activation-dependent currents (activation minus baseline) for each
condition, expressed as mean ± SEM
Fig. 4 Orai1 and KCa3.1 proteins co-immunoprecipitate. a Western
blots using either an antibody recognising the myc epitope (left) or
an antibody recognising the FLAG epitope (right) of HEK293 cell
lysates. Lysates expressed either myc epitope tagged Orai1, FLAG
epitope-tagged KCa3.1, or both as indicated in the panel above. b
Lysates of HEK293 cells expressing the indicated proteins were
immunoprecipitated with an anti-myc antibody. Immunoprecipitates
were then Western blotted using either an anti-Orai1 antibody (left)
or an anti-FLAG antibody (right). c As (b) except cell lysates were
immunoprecipitated with an anti-FLAG antibody and then Western
blotted with an anti-FLAG antibody (left) or an anti-myc antibody
(right). Blots shown are representative of 3 independent experiments
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(Fig. 4c). Again co-immunoprecipitation was dependent
on co-expression of both proteins in HEK293 cells.
In contrast, under identical reaction conditions, no
co-immunoprecipitation of KCa3.1-FLAG protein was
observed when the anti c-myc antibody was used to
immunoprecipitate Orai2-myc protein (Fig. 5a and b).
Similarly in the reverse experiment using the anti-
FLAG antibody to immunoprecipitate KCa3.1-FLAG,
no Orai2-myc protein was co-immunoprecipitated
(Fig. 5c). We were unable to test for Orai3-myc and
KCa3.1-FLAG co-immunoprecipitation, since we were
unable to satisfactorily demonstrate co-expression of
Orai3-myc and KCa3.1-FLAG protein in HEK293 cells
(data not shown).
Orai1 and KCa3.1 co-localise in the plasma membrane of
HEK-293 cells
To assess whether Orai1 and KCa3.1 co-localise in plasma
membranes, we dually transfected HEK-293 with FLAG-
tagged KCa3.1and myc-tagged Orai1 or Orai2 (HLMCs
cannot be transfected efficiently). Subsequent analysis of
the immunostained tags using confocal microscopy
showed clear co-localisation of Orai1 and KCa3.1 in the
HEK293 plasma membrane (Fig. 6a and b), but minimal
co-localisation of KCa3.1 with Orai2 (Fig. 6c and d).
Discussion
The release of mast cell mediators following cell activation
requires the influx of extracellular Ca2+. We and others
have shown that members of the Orai channel family play
a major role in this Ca2+ influx in both human and rodent
mast cells [3, 4]. The intermediate conductance Ca2+ acti-
vated K+ channel KCa3.1 is also a key regulator of Ca
2+ in-
flux into mast cells [13–15], as activated KCa3.1 channels
maintain the driving force for Ca2+ entry by hyperpolaris-
ing the plasma membrane. Here we show for the first time
that KCa3.1 activation has an obligate dependency on Ca
2+
influx through Orai1 channels, which appears to be medi-
ated via an intimate spatiotemporal interaction.
We have demonstrated previously that KCa3.1 opens in
HLMCs following FcεRI-dependent activation, disap-
pears on removal of extracellular Ca2+, and does not
open after stimulation with other agonists which globally
raise intracellular Ca2+ in HLMCs such as chemokines,
PAF, LPA and the Ca2+ ionophore A23187 [13, 17, 25].
This suggested that tight Ca2+ microdomains regulate
KCa3.1 activity. Here we found that activation of FcεRI-
dependent KCa3.1 currents required the presence of
extracellular Ca2+, were attenuated by a selective Orai
channel blocker, and were ablated by transduction of a
dominant-negative Orai1 mutant. This implies that Ca2+
engages KCa3.1 at the point of entry through Orai chan-
nels. The ability of KCa3.1 to co-immunoprecipitate and
co-localise with Orai1, the dominant Orai channel in
HLMCs, suggests the presence of a tight Orai1-KCa3.1
signalplex in the HLMC plasma membrane.
It is perhaps surprising that Orai1 interacted physically
with KCa3.1 but Orai2 did not. However, Orai1 contains
a C-terminal SHYA sequence which may act as a PDZ
binding site. Although it does not conform to the class
II or class III binding sites which are characterised by X-
Hydrophobic-X-Hydrophobic or X-Neg charged-X-V/I/
Fig. 5 Orai2 and KCa3.1 proteins do not co-immunoprecipitate under
the conditions used to co-immunoprecipitate Orai1 and KCa3.1. a
Western blots using either an antibody recognising the myc epitope
(left) or an antibody recognising the FLAG epitope (right) of HEK293
cell lysates. Lysates expressed either myc epitope tagged Orai2, FLAG
epitope-tagged KCa3.1, or both as indicated in the panel above. b
HEK293 cell lysates expressing the proteins indicated in the panel
above were immunoprecipitated with an anti-myc antibody.
Immunoprecipitates were then Western blotted using either an
anti-Orai2 antibody (left) or an anti-FLAG antibody (right). Control
HEK293 cell lysate expressing KCa3.1-FLAG protein. c As (b) except
cell lysates were immunoprecipitated with an anti-FLAG antibody
and then Western blotted with an anti-Orai2 antibody (left) or an
anti-FLAG antibody (right). Control HEK293 cell lysate expressing
Orai2-myc protein. Blots shown are representative of 3
independent experiments
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Fig. 6 (See legend on next page.)
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A, there is variation and other sequences will bind as
well. If this is a PDZ binding site, then there is the po-
tential for KCa3.1 and Orai1 to form part of a macromol-
ecular complex organised by PDZ-containing scaffolding
proteins. Orai1also interacts with TRPC family channels
via a direct physical interaction at the N- and C-termini,
but this is also true for Orai2 and Orai3 [26], so it seems
unlikely that this is the mechanism mediating the inter-
action of Orai1 with KCa3.1. However, the N-terminus of
Orai1 but not Orai3 forms a membrane-delimited sig-
nalplex with NFAT via the scaffolding protein AKAP79
[27]. Further work will be required to establish the exact
mechanism of the KCa3.1-Orai1 interaction.
Orai1 currents are only activated following store de-
pletion by STIM1, and our data do not directly address
whether STIM1 plays a role in the co-regulation of
Orai1 and KCa3.1. However, the co-immunoprecipitation
and confocal imaging experiments were performed in
resting cells following over-expression, while the func-
tional interaction is evident in lung mast cells following
IgE-dependent activation, so it is likely that the inter-
action occurs independently of Ca2+ store depletion.
This would be in keeping with previous studies showing
that another Ca2+ activated K+ channel, KCa1.1 (bKCa),
forms a signalling complex consisting of the β2-adrenor-
eceptor, the L-type calcium channel Cav1.2 and the A-
kinase anchoring proteins AKAP79 and AKAP150 [28].
The Ca2+required for activation of KCa1.1 is provided by
voltage-gated Ca2+ channels, either Cav1.2, Cav2.1 or
Cav2.2 [29]. There is also limited evidence that KCa3.1
may form a signalplex with the β2-adrenoreceptor [30],
so it will be interesting to assess whether a similar com-
plex utilises KCa3.1 and Orai1.
A close association of KCa1.1 with voltage-gated Ca
2+
channels is thought to be necessary because activation
requires a relatively high intracellular Ca2+ concentration
of 10 μM or more. Such concentrations are thought only
to be found in so called Ca2+ nanodomains in the imme-
diate vicinity of the open Cav channels. In contrast,
KCa3.1 has a far higher affinity for Ca
2+, with a value for
half maximal activation (EC50) of approximately 0.3 μM
[31]. This high affinity has been considered to obviate
the requirement for a close interaction with a Ca2+
source [32]. However, it is clear that if KCa3.1 is coupled
closely to a particular Ca2+ entry pathway and signalplex,
there will be greater sensitivity and specificity with
regards to KCa3.1 channel activation. Furthermore, Orai
channels have a very low single channel conductance, es-
timated to be more than 100-fold lower than for
voltage-gated Ca2+ channels [33, 34]. As a consequence
the increase in Ca2+ concentration in the vicinity of an
open Orai channel is likely to be relatively small. In mast
cells the Ca2+ concentration has been estimated to be of
the order of 2 μM at a distance of 10 nm from an open
Orai channel, falling steeply with increasing distance
[35]. While clustering of (open) Orai channels in mast
cells would lead to considerably higher local Ca2+con-
centrations, a close association of Orai1 with KCa3.1 in
mast cells may therefore be required to ensure efficient
activation of KCa3.1 channels and so regulation of Ca
2+
influx.
The importance of Ca2+ microdomains for the regula-
tion of specific Ca2+-dependent cell responses was
highlighted recently by Parekh [35, 36]. For example
there is evidence of distinct Orai channel signalling do-
mains regulating the activity plasma membrane-associated
enzymes such as Syk and cPLA2, and transcription factors
such as NFAT [27, 37, 38]. A close KCa3.1-Orai1 inter-
action would therefore appear to make sense from several
perspectives. The activation of KCa3.1 independently of
global intracellular Ca2+ will fine-tune signals requiring
Orai1 activation, with rapid and selective feedback en-
suring that the Ca2+ signal is maintained, supporting
Ca2+-dependent local membrane-associated signalling
events. Furthermore, modulation of KCa3.1 by de-
phosphorylation for example [39], or β2-adrenoceptor
signalling [30], has the potential to feedback on Orai1
and limit Ca2+ entry. In resting cells where KCa3.1 and
perhaps Orai1 expression may be relatively low [40],
their co-localisation would ensure that efficient signal-
ling could occur during an initial cell response. In
addition, in cells expressing numerous KCa3.1 and Orai
channels, there would be enhanced sensitivity to low
grade stimuli, thus increasing the dynamic range, speci-
ficity and fidelity of the response to an external stimu-
lus. It is also evident that KCa3.1 and Orai channels are
localised to specific regions of activated cells. For example,
localised KCa3.1 channel activity regulates shrinkage of
(See figure on previous page.)
Fig. 6 Orai1 and KCa3.1 co-localise in the plasma membrane. a HEK293 cells, dually transfected with FLAG-tagged KCa3.1 and myc-tagged Orai1
and then immunostained, show co-localisation in the plasma membrane by single plane confocal microscopy (top panels). Dually transfected
HEK293 show negative staining for appropriate isotype controls (bottom panels): rabbit IgG control, dual stained with anti-myc, and mouse IgG1
control dual stained with anti-FLAG. b Fluorescence intensity plot shows increased fluorescence at the plasma membrane. myc-Orai1 is shown in
green and FLAG-KCa3.1 in red. Arrows indicate increased fluorescence where the region of interest (ROI) intersects the plasma membrane.
c HEK293 cells, dually transfected with FLAG-tagged KCa3.1 and myc-tagged Orai2 and then immunostained, show poor co-localisation in the
plasma membrane by single plane confocal microscopy (top panels). Dually transfected HEK293 show negative staining for appropriate isotype
controls (bottom panels): rabbit IgG control, dual stained with anti-myc, and mouse IgG1 control dual stained with anti-FLAG. d Fluorescence
intensity plot shows poor co-localisation of KCa3.1 and Orai2 signals. myc-Orai2 is shown in green and FLAG-KCa3.1 in red. Scale bars are 10 μm
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the uropod in migrating cells even although the channels
are distributed throughout the plasma membrane [41],
while both Orai1 and KCa3.1 co-localise at the immuno-
logical synapse in activated T cells [42, 43]. Their ability to
form a close physical interaction would ensure that they
interact specifically in these regions. It is also clear that
Orai1-3 have distinct physiological roles and electro-
physiological characteristics [6, 44, 45]. A selective inter-
action between Orai1 and KCa3.1 would ensure that
unwanted KCa3.1 activation does not occur in Orai2 or
Orai3-dependent cell responses. The physiological rele-
vance of this interpretation is supported by previous work
in HLMCs. These cells express both Orai1 and Orai2 pro-
tein, but FcεRI-dependent degranulation and leukotriene
release is driven largely by Orai1 [5].
Conclusions
There is a close spatio-temporal and functional inter-
action between KCa3.1 channels and Orai1 channels in
HLMCs with evidence of a physical interaction leading
to a restricted membrane-delimited signalplex. This is
likely to facilitate the selective activation and fine-tuning
of KCa3.1-Orai1-dependent cell processes.
Methods
Human mast cell purification and cell culture
HLMCs were purified from enzymatically dispersed
healthy human lung obtained within one hour of surgery
for lung cancer [46, 47]. Cells were cultured in Dulbec-
co’s modified Eagle’s medium (DMEM, Invitrogen) con-
taining 10 % foetal calf serum and 100 ng/ml stem cell
factor, 50 ng/ml IL-6 and 10 ng/ml IL-10 as previously
described [47]. All human subjects donating lung tissue
gave written informed consent and the study was ap-
proved by the Leicestershire Research Ethics Committee.
Final mast cell purity was >99 %.
HEK293 cells were cultured in DMEM containing
10 % FCS.
Orai and KCa3.1 protein expression and
co-immunoprecipitation
The construction of vectors directing the expression
of c-Myc epitope-tagged Orai1 and Orai2 has been
described previously [3]. Briefly full length Orai1 and
−2 cDNAs were cloned in frame immediately follow-
ing the c-Myc epitope tag in vector pCruz Myc
(Santa Cruz Biotechnology Inc). For the expression of
FLAG epitope tagged KCa3.1, a PCR fragment con-
taining the entire human KCa3.1open reading frame
(ORF), an EcoR1 site immediately adjacent to the
ATG initiation codon and an Xho1 site immediately
adjacent to the stop codon was cloned into the
EcoR1/Xho1 sites of vector pcDNA3 (Invitrogen). The
stop codon was then removed by site directed
mutagenesis. Oligonucleotides 5′ TCGAGGACTA-
CAAAGACGATGACGACAAGTAGC 3′ and 5′ TCG
AGCTACTTGTCGTCATCGTCTTTGTAGTCC 3′ en-
coding the FLAG eiptope (DYKDDDDK) were annealed
together and inserted at the Xho1 site of the mutant
KCa3.1 construct. The resulting vector directs the ex-
pression of KCa3.1 with a FLAG epitope in frame with
the last codon of the KCa3.1 ORF. The construct was
verified by DNA sequencing.
HEK293 cells were transiently transfected with vectors
directing the expression of c-Myc epitope tagged Orai1
and −2 and/or FLAG epitope-tagged KCa3.1 using Gene-
Juice transfection reagent (Merck Bioscience Ltd). Cells
were harvested for lysis 24 h later and lysed in a buffer
containing 50 mM Tris pH8.0, 150 mM NaCl, 1 %
Triton X-100 and a protease inhibitor cocktail (Sigma).
Lysates were centrifuged at 13,200 rpm for 15 min at 4 °C
and supernatants used for co-immunoprecipitation
experiments.
For the immunoprecipitation of Orai1 or Orai2, superna-
tants were pre-cleared with protein G-sepharose beads and
then incubated with a mouse monoclonal anti-c-Myc anti-
body (clone 9E10, Sigma) for 16–18 h at 4 °C. Immune
complexes were recovered by incubation with protein G-
sepharose beads for 15 min at 4 °C and washed 5 times
with lysis buffer. Immunoprecipitation of KCa3.1 was as
above except rabbit polyclonal anti-FLAG antibody (Sigma)
and protein A-agarose were used.
Proteins were separated on 12 % Bis-Tris Nu-Page gels
(Invitrogen) and then blotted onto polyvinylidene fluoride
membranes. Membranes were blocked with 5 % nonfat
milk in phosphate buffered saline. Blots were then probed
with rabbit polyclonal antibodies recognising either Orai1
or Orai2 (both Alomone Labs Ltd) [3], anti-c-Myc antibody
and/or anti-FLAG antibody as required. Blots were subse-
quently probed with Clean-Blot IP-horseradish peroxidase
conjugate (Thermo Scientific). Immunoreactive bands were
visualised using Pierce ECL Western Blotting Substrate
(Fisher Scientific, Loughborough, United Kingdom).
HLMCs were transduced with adenoviruses expressing
Orai E106Q and GFP control as described previously
[5]. HLMCs were also transduced with GFP-KCa3.1
using the same methodology.
Patch clamp electrophysiology
The whole-cell variant of the patch-clamp technique was
used [3, 13]. Patch pipettes were made from borosilicate
fibre-containing glass (Harvard Instruments, UK), and
their tips were heat polished, typically resulting in resis-
tances of 4–6 MΩ. The standard pipette solution con-
tained (in mM): KCl (140), MgCl2 (2), HEPES (10),
NaATP (2) GTP (0.1); pH 7.3 with KOH. The standard
external solution contained (in mM), NaCl (140), KCl
(5), CaCl2 (2), MgCl2 (1), HEPES (10) and glucose (5);
Duffy et al. Cell Communication and Signaling  (2015) 13:32 Page 8 of 10
pH 7.3 with NaOH. For recording, mast cells were
placed in 35 mm dishes containing standard external
solution.
Whole cell currents were recorded using an Axoclamp
200A amplifier (Axon Instruments, Foster City, CA,
USA), and currents usually evoked by applying voltage
commands to a range of potentials in 10 mV steps from
a holding potential of −20 mV. The currents were digi-
tised (sampled at a frequency of 10 kHz), stored on com-
puter and subsequently analysed using pClamp10
software (Axon Instruments). Capacitance transients
were minimised using the capacitance neutralisation cir-
cuits on the amplifier. Correction for series resistance
was not routinely applied. Experiments were performed
at 27 °C, temperature being controlled by a Peltier de-
vice. Drugs were added directly to the recording cham-
ber as required.
Confocal microscopy
HEK-293 cells (3×105) were seeded on 25 mm cover
glasses and 24 h later dual-transfected with FLAG-
tagged KCa3.1 and myc-tagged Orai1 or Orai2 using
GeneJuice Transfection Reagent (Novagen). After
24 h, cells were methanol fixed and immunostained.
The myc tag was detected with anti-myc 9E10 (gift
from ADAS, Nottingham, UK) plus rabbit anti-mouse
FITC (F0313, DAKO) alongside anti-mouse IgG1
(X0931, DAKO) isotype control. The FLAG tag was
detected by anti-FLAG (F7425, Sigma) plus sheep
anti-rabbit RPE (STAR35, AbD Serotec) alongside
anti-rabbit IgG (550875, BD Pharmingen) isotype con-
trol. Fluorescence microscopy was performed using a
Leica TCS SP5 confocal microscope and analysed with
ImageJ software. Identical exposures were used for
isotype controls.
Statistical analysis
Data were compared using paired or unpaired t test as ap-
propriate. P < 0.05 was considered statistically significant.
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